COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
USA - NASDAQ:COLL - US19459J1043 - Common Stock
34.92 USD
-2.4 (-6.43%)
34.9 USD
-0.02 (-0.06%)
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 196 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. COLL may be a bit undervalued, certainly considering the very reasonable score on growth This makes COLL very considerable for value investing!
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
In the past year COLL had a positive cash flow from operations.
Of the past 5 years COLL 4 years were profitable.
COLL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
COLL has a better Return On Assets (2.28%) than 84.18% of its industry peers.
The Return On Equity of COLL (15.62%) is better than 89.29% of its industry peers.
With an excellent Return On Invested Capital value of 7.69%, COLL belongs to the best of the industry, outperforming 84.18% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COLL is below the industry average of 15.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROIC | 7.69% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
The Profit Margin of COLL (5.13%) is better than 83.67% of its industry peers.
In the last couple of years the Profit Margin of COLL has declined.
COLL has a better Operating Margin (18.35%) than 87.24% of its industry peers.
COLL's Operating Margin has improved in the last couple of years.
COLL's Gross Margin of 56.69% is fine compared to the rest of the industry. COLL outperforms 65.82% of its industry peers.
In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
Compared to 1 year ago, COLL has less shares outstanding
Compared to 5 years ago, COLL has less shares outstanding
Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.13, we must say that COLL is in the distress zone and has some risk of bankruptcy.
COLL's Altman-Z score of 1.13 is fine compared to the rest of the industry. COLL outperforms 60.20% of its industry peers.
COLL has a debt to FCF ratio of 4.08. This is a neutral value as COLL would need 4.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.08, COLL belongs to the top of the industry, outperforming 86.73% of the companies in the same industry.
A Debt/Equity ratio of 3.27 is on the high side and indicates that COLL has dependencies on debt financing.
With a Debt to Equity ratio value of 3.27, COLL is not doing good in the industry: 79.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 1.13 |
ROIC/WACC0.8
WACC9.63%
2.3 Liquidity
COLL has a Current Ratio of 1.18. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, COLL is not doing good in the industry: 77.04% of the companies in the same industry are doing better.
A Quick Ratio of 1.10 indicates that COLL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.10, COLL is doing worse than 71.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 48.19% over the past year.
The Earnings Per Share has been growing by 154.78% on average over the past years. This is a very strong growth
COLL shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.61%.
COLL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.31% yearly.
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
3.2 Future
Based on estimates for the next years, COLL will show a small growth in Earnings Per Share. The EPS will grow by 4.42% on average per year.
Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 3.17% on average per year.
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 5.33 indicates a rather cheap valuation of COLL.
COLL's Price/Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 95.92% of the companies in the same industry.
COLL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.27.
With a Price/Forward Earnings ratio of 4.11, the valuation of COLL can be described as very cheap.
COLL's Price/Forward Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 96.94% of the companies in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.33 | ||
| Fwd PE | 4.11 |
4.2 Price Multiples
98.98% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, COLL is valued cheaper than 96.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.45 | ||
| EV/EBITDA | 4.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y4.88%
5. Dividend
5.1 Amount
COLL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.92
-2.4 (-6.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners117.03%
Inst Owner Change-2.57%
Ins Owners1.55%
Ins Owner Change2.04%
Market Cap1.10B
Analysts81.82
Price Target45.49 (30.27%)
Short Float %13.98%
Short Ratio10.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.92%
Min EPS beat(2)1.88%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)3.95%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)9
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-27.3%
Revenue beat(2)2
Avg Revenue beat(2)1.62%
Min Revenue beat(2)1.34%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.9%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)7
Avg Revenue beat(16)-4.84%
PT rev (1m)0.9%
PT rev (3m)3.72%
EPS NQ rev (1m)-0.92%
EPS NQ rev (3m)22.35%
EPS NY rev (1m)19.88%
EPS NY rev (3m)19.88%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)2.03%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.33 | ||
| Fwd PE | 4.11 | ||
| P/S | 1.56 | ||
| P/FCF | 5.45 | ||
| P/OCF | 5.41 | ||
| P/B | 4.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.68 |
EPS(TTM)6.55
EY18.76%
EPS(NY)8.51
Fwd EY24.36%
FCF(TTM)6.41
FCFY18.35%
OCF(TTM)6.46
OCFY18.5%
SpS22.44
BVpS7.37
TBVpS-22.1
PEG (NY)0.17
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROCE | 11.5% | ||
| ROIC | 7.69% | ||
| ROICexc | 9.58% | ||
| ROICexgc | N/A | ||
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% | ||
| FCFM | 28.54% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 0.79% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.9 | ||
| Cash Conversion | 59.64% | ||
| Profit Quality | 556.38% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 1.13 |
F-Score5
WACC9.63%
ROIC/WACC0.8
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
EBIT growth 1Y-36.29%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year147.2%
EBIT Next 3Y28.36%
EBIT Next 5Y16.08%
FCF growth 1Y-14.2%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y-13.96%
OCF growth 3Y25.54%
OCF growth 5Y49.12%